Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
J Clin Endocrinol Metab ; 106(7): e2527-e2534, 2021 06 16.
Article in English | MEDLINE | ID: mdl-33780545

ABSTRACT

CONTEXT: In primary hyperparathyroidism (PHPT) bone mineral density (BMD) is typically decreased in cortical bone and relatively preserved in trabecular bone. An increased fracture rate is observed however not only at peripheral sites but also at the spine, and fractures occur at higher BMD values than expected. We hypothesized that components of bone quality other than BMD are affected in PHPT as well. OBJECTIVE: To evaluate bone material properties using impact microindentation (IMI) in PHPT patients. METHODS: In this cross-sectional study, the Bone Material Strength index (BMSi) was measured by IMI at the midshaft of the tibia in 37 patients with PHPT (28 women), 11 of whom had prevalent fragility fractures, and 37 euparathyroid controls (28 women) matched for age, gender, and fragility fracture status. RESULTS: Mean age of PHPT patients and controls was 61.8 ±â€…13.3 and 61.0 ±â€…11.8 years, respectively, P = .77. Calcium and PTH levels were significantly higher in PHPT patients but BMD at the lumbar spine (0.92 ±â€…0.15 vs 0.89 ±â€…0.11, P = .37) and the femoral neck (0.70 ±â€…0.11 vs 0.67 ±â€…0.07, P = .15) were comparable between groups. BMSi however was significantly lower in PHPT patients than in controls (78.2 ±â€…5.7 vs 82.8 ±â€…4.5, P < .001). In addition, BMSi was significantly lower in 11 PHPT patients with fragility fractures than in the 26 PHPT patients without fragility fractures (74.7 ±â€…6.0 vs 79.6 ±â€…5.0, P = .015). CONCLUSION: Our data indicate that bone material properties are altered in PHPT patients and most affected in those with prevalent fractures. IMI might be a valuable additional tool in the evaluation of bone fragility in patients with PHPT.


Subject(s)
Body Weights and Measures/methods , Health Status Indicators , Hyperparathyroidism, Primary/physiopathology , Osteoporotic Fractures/etiology , Tibial Fractures/etiology , Absorptiometry, Photon , Body Weights and Measures/instrumentation , Bone Density , Calcium/blood , Cancellous Bone/physiopathology , Cortical Bone/physiopathology , Cross-Sectional Studies , Female , Femur Neck/diagnostic imaging , Humans , Hyperparathyroidism, Primary/complications , Lumbar Vertebrae/diagnostic imaging , Male , Microtechnology/instrumentation , Microtechnology/methods , Middle Aged , Osteoporotic Fractures/physiopathology , Parathyroid Hormone/blood , Tibia/physiopathology , Tibial Fractures/physiopathology
2.
Diabetologia ; 60(6): 989-997, 2017 06.
Article in English | MEDLINE | ID: mdl-28386638

ABSTRACT

AIMS/HYPOTHESIS: Elevated levels of lipoprotein(a) [Lp(a)] are an independent risk factor for cardiovascular disease (CVD), particularly in individuals with type 2 diabetes. Although weight loss improves conventional risk factors for CVD in type 2 diabetes, the effects on Lp(a) are unknown and may influence the long-term outcome of CVD after diet-induced weight loss. The aim of this clinical study was to determine the effect of diet-induced weight loss on Lp(a) levels in obese individuals with type 2 diabetes. METHODS: Plasma Lp(a) levels were determined by immunoturbidimetry in plasma obtained before and after 3-4 months of an energy-restricted diet in four independent study cohorts. The primary cohort consisted of 131 predominantly obese patients with type 2 diabetes (cohort 1), all participants of the Prevention Of Weight Regain in diabetes type 2 (POWER) trial. The secondary cohorts consisted of 30 obese patients with type 2 diabetes (cohort 2), 37 obese individuals without type 2 diabetes (cohort 3) and 26 obese individuals without type 2 diabetes who underwent bariatric surgery (cohort 4). RESULTS: In the primary cohort, the energy-restricted diet resulted in a weight loss of 9.9% (95% CI 8.9, 10.8) and improved conventional CVD risk factors such as LDL-cholesterol levels. Lp(a) levels increased by 14.8 nmol/l (95% CI 10.2, 20.6). In univariate analysis, the change in Lp(a) correlated with baseline Lp(a) levels (r = 0.38, p < 0.001) and change in LDL-cholesterol (r = 0.19, p = 0.033). In cohorts 2 and 3, the weight loss of 8.5% (95% CI 6.5, 10.6) and 6.5% (95% CI 5.7, 7.2) was accompanied by a median increase in Lp(a) of 13.5 nmol/l (95% CI 2.3, 30.0) and 11.9 nmol/l (95% CI 5.7, 19.0), respectively (all p < 0.05). When cohorts 1-3 were combined, the diet-induced increase in Lp(a) correlated with weight loss (r = 0.178, p = 0.012). In cohort 4, no significant change in Lp(a) was found (-7.0 nmol/l; 95% CI -18.8, 5.3) despite considerable weight loss (14.0%; 95% CI 12.2, 15.7). CONCLUSIONS/INTERPRETATION: Diet-induced weight loss was accompanied by an increase in Lp(a) levels in obese individuals with and without type 2 diabetes while conventional CVD risk factors for CVD improved. This increase in Lp(a) levels may potentially antagonise the beneficial cardiometabolic effects of diet-induced weight reduction.


Subject(s)
Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/diet therapy , Lipoprotein(a)/blood , Obesity/blood , Obesity/diet therapy , Weight Loss/physiology , Adult , Aged , Bariatric Surgery , Diabetes Mellitus, Type 2/surgery , Diet, Reducing , Female , Humans , Male , Middle Aged , Obesity/surgery , Prospective Studies
3.
Metabolism ; 65(11): 1614-1620, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27733249

ABSTRACT

INTRODUCTION: Weight loss interventions such as Roux-en-Y gastric bypass (RYGB) and very low calorie diets (VLCD) lead to improvement of glucose metabolism in obese individuals with type-2 diabetes. Weight loss can also positively influence the unfavorable inflammatory profile associated with obesity. However, a direct comparison of the effect of VLCD and RYGB on systemic inflammation is lacking. METHODS: Systemic inflammation was investigated in age- and BMI-matched morbidly obese T2DM women by determining the number and activation- or memory status of peripheral blood leukocytes by flow cytometry, in addition to measuring circulating levels of cytokines and CRP. Systemic inflammation was assessed one month before and three months after RYGB (n=15) or VLCD (n=12). An age matched group of lean women (n=12) was studied as control group. RESULTS: Three months after the intervention, CRP and leptin levels were reduced whereas adiponectin levels were increased both by RYGB and VLCD. TNF-α levels were increased by RYGB, but reduced by VLCD. IL-2 and IL-6 levels were reduced and IL-4 levels were increased by VLCD but not affected by RYGB. The number of activated peripheral cytotoxic T (CD8+CD25+) and B (CD19+CD38+) cells was significantly higher after RYGB than after VLCD. CONCLUSION: In conclusion, RYGB and VLCD have differential effects on the activation status of peripheral leukocytes and levels of cytokines in obese women with T2DM, despite comparable weight loss three months after the intervention. VLCD seems to have more favorable effects on the inflammatory profile as compared to RYGB.


Subject(s)
Caloric Restriction , Gastric Bypass/methods , Inflammation/metabolism , Obesity, Morbid/diet therapy , Obesity, Morbid/surgery , Weight Loss , Adiponectin/blood , Adult , Blood Glucose/metabolism , C-Reactive Protein/metabolism , Cytokines/blood , Diabetes Mellitus, Type 2/metabolism , Female , Humans , Insulin/blood , Leptin/blood , Lymphocyte Count , Middle Aged , Treatment Outcome
4.
Diabetologia ; 59(9): 2013-7, 2016 09.
Article in English | MEDLINE | ID: mdl-27312699

ABSTRACT

AIMS/HYPOTHESIS: Dicarbonyl compounds are formed as byproducts of glycolysis and are key mediators of diabetic complications. However, evidence of postprandial α-dicarbonyl formation in humans is lacking, and interventions to reduce α-dicarbonyls have not yet been investigated. Therefore, we investigated postprandial α-dicarbonyl levels in obese women without and with type 2 diabetes. Furthermore, we evaluated whether a diet very low in energy (very low calorie diet [VLCD]) or Roux-en-Y gastric bypass (RYGB) reduces α-dicarbonyl stress in obese women with type 2 diabetes. METHODS: In lean (n = 12) and obese women without (n = 27) or with type 2 diabetes (n = 27), we measured the α-dicarbonyls, methylglyoxal (MGO), glyoxal (GO) and 3-deoxyglucosone (3-DG), and glucose in fasting and postprandial plasma samples obtained during a mixed meal test. Obese women with type 2 diabetes underwent either a VLCD or RYGB. Three weeks after the intervention, individuals underwent a second mixed meal test. RESULTS: Obese women with type 2 diabetes had higher fasting and particularly higher postprandial plasma α-dicarbonyl levels, compared with those without diabetes. After three weeks of a VLCD, postprandial α-dicarbonyl levels in diabetic women were significantly reduced (AUC MGO -14%, GO -16%, 3-DG -25%), mainly through reduction of fasting plasma α-dicarbonyls (MGO -13%, GO -13%, 3-DG -33%). Similar results were found after RYGB. CONCLUSIONS/INTERPRETATION: This study shows that type 2 diabetes is characterised by increased fasting and postprandial plasma α-dicarbonyl stress, which can be reduced by improving glucose metabolism through a VLCD or RYGB. These data highlight the potential to reduce reactive α-dicarbonyls in obese individuals with type 2 diabetes. TRIAL REGISTRATION: ClinicalTrials.gov NCT01167959.


Subject(s)
Caloric Restriction/methods , Diabetes Mellitus, Type 2/surgery , Diabetes Mellitus, Type 2/therapy , Gastric Bypass/methods , Obesity/surgery , Obesity/therapy , Adult , Diabetes Mellitus, Type 2/blood , Fasting/blood , Female , Humans , Middle Aged , Obesity/blood , Oxidative Stress/physiology , Postprandial Period/physiology
5.
Nutrients ; 7(9): 7676-90, 2015 Sep 11.
Article in English | MEDLINE | ID: mdl-26378572

ABSTRACT

Obese women with type 2 diabetes mellitus (T2DM) have more inflammation in their subcutaneous white adipose tissue (sWAT) than age-and-BMI similar obese women with normal glucose tolerance (NGT). We aimed to investigate whether WAT fatty acids and/or oxylipins are associated with the enhanced inflammatory state in WAT of the T2DM women. Fatty acid profiles were measured in both subcutaneous and visceral adipose tissue (vWAT) of 19 obese women with NGT and 16 age-and-BMI similar women with T2DM. Oxylipin levels were measured in sWAT of all women. Arachidonic acid (AA) and docosahexaenoic acid (DHA) percentages were higher in sWAT, but not vWAT of the T2DM women, and AA correlated positively to the gene expression of macrophage marker CD68. We found tendencies for higher oxylipin concentrations of the 5-LOX leukotrienes in sWAT of T2DM women. Gene expression of the 5-LOX leukotriene biosynthesis pathway was significantly higher in sWAT of T2DM women. In conclusion, AA and DHA content were higher in sWAT of T2DM women and AA correlated to the increased inflammatory state in sWAT. Increased AA content was accompanied by an upregulation of the 5-LOX pathway and seems to have led to an increase in the conversion of AA into proinflammatory leukotrienes in sWAT.


Subject(s)
Arachidonate 5-Lipoxygenase/analysis , Arachidonic Acid/analysis , Diabetes Mellitus, Type 2/enzymology , Docosahexaenoic Acids/analysis , Inflammation Mediators/analysis , Inflammation/enzymology , Obesity, Morbid/enzymology , Signal Transduction , Subcutaneous Fat/enzymology , 5-Lipoxygenase-Activating Proteins/genetics , Adult , Antigens, CD/genetics , Antigens, Differentiation, Myelomonocytic/genetics , Arachidonate 5-Lipoxygenase/genetics , Diabetes Mellitus, Type 2/diagnosis , Diabetes Mellitus, Type 2/genetics , Dipeptidases/genetics , Female , Humans , Inflammation/diagnosis , Intra-Abdominal Fat/enzymology , Leukotrienes/analysis , Middle Aged , Netherlands , Obesity, Morbid/diagnosis , Obesity, Morbid/genetics , Obesity, Morbid/surgery , Up-Regulation
6.
Diabetes Care ; 37(12): 3150-6, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25315204

ABSTRACT

OBJECTIVE: Obesity and type 2 diabetes mellitus (T2DM) have been associated with increased levels of circulating branched-chain amino acids (BCAAs) that may be involved in the pathogenesis of insulin resistance. However, weight loss has not been consistently associated with the reduction of BCAA levels. RESEARCH DESIGN AND METHODS: We included 30 obese normal glucose-tolerant (NGT) subjects, 32 obese subjects with T2DM, and 12 lean female subjects. Obese subjects underwent either a restrictive procedure (gastric banding [GB], a very low-calorie diet [VLCD]), or a restrictive/bypass procedure (Roux-en-Y gastric bypass [RYGB] surgery). Fasting blood samples were taken for the determination of amine group containing metabolites 4 weeks before, as well as 3 weeks and 3 months after the intervention. RESULTS: BCAA levels were higher in T2DM subjects, but not in NGT subjects, compared with lean subjects. Principal component (PC) analysis revealed a concise PC consisting of all BCAAs, which showed a correlation with measures of insulin sensitivity and glucose tolerance. Only after the RYGB procedure, and at both 3 weeks and 3 months, were circulating BCAA levels reduced. CONCLUSIONS: Our data confirm an association between deregulation of BCAA metabolism in plasma and insulin resistance and glucose intolerance. Three weeks after undergoing RYGB surgery, a significant decrease in BCAAs in both NGT as well as T2DM subjects was observed. After 3 months, despite inducing significant weight loss, neither GB nor VLCD induced a reduction in BCAA levels. Our results indicate that the bypass procedure of RYGB surgery, independent of weight loss or the presence of T2DM, reduces BCAA levels in obese subjects.


Subject(s)
Amino Acids, Branched-Chain/blood , Caloric Restriction , Diabetes Mellitus, Type 2/complications , Gastric Bypass , Obesity/surgery , Weight Loss/physiology , Adult , Down-Regulation , Female , Glucose Intolerance/blood , Glucose Intolerance/complications , Glucose Intolerance/diet therapy , Glucose Intolerance/surgery , Humans , Insulin Resistance , Middle Aged , Obesity/complications , Obesity/diet therapy
7.
Diabetologia ; 57(11): 2384-92, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25099943

ABSTRACT

AIMS/HYPOTHESIS: Not all obese individuals develop type 2 diabetes. Why some obese individuals retain normal glucose tolerance (NGT) is not well understood. We hypothesise that the biochemical mechanisms that underlie the function of adipose tissue can help explain the difference between obese individuals with NGT and those with type 2 diabetes. METHODS: RNA sequencing was used to analyse the transcriptome of samples extracted from visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) of obese women with NGT or type 2 diabetes who were undergoing bariatric surgery. The gene expression data was analysed by bioinformatic visualisation and statistical analyses techniques. RESULTS: A network-based approach to distinguish obese individuals with NGT from obese individuals with type 2 diabetes identified acetyl-CoA metabolic network downregulation as an important feature in the pathophysiology of type 2 diabetes in obese individuals. In general, genes within two reaction steps of acetyl-CoA were found to be downregulated in the VAT and SAT of individuals with type 2 diabetes. Upon weight loss and amelioration of metabolic abnormalities three months following bariatric surgery, the expression level of these genes recovered to levels seen in individuals with NGT. We report four novel genes associated with type 2 diabetes and recovery upon weight loss: ACAT1 (encoding acetyl-CoA acetyltransferase 1), ACACA (encoding acetyl-CoA carboxylase α), ALDH6A1 (encoding aldehyde dehydrogenase 6 family, member A1) and MTHFD1 (encoding methylenetetrahydrofolate dehydrogenase). CONCLUSIONS/INTERPRETATION: Downregulation of the acetyl-CoA network in VAT and SAT is an important feature in the pathophysiology of type 2 diabetes in obese individuals. ACAT1, ACACA, ALDH6A1 and MTHFD1 represent novel biomarkers in adipose tissue associated with type 2 diabetes in obese individuals.


Subject(s)
Acetyl Coenzyme A/metabolism , Adipose Tissue/metabolism , Diabetes Mellitus, Type 2/metabolism , Obesity/enzymology , Acetyl-CoA C-Acetyltransferase/genetics , Acetyl-CoA Carboxylase/genetics , Adipocytes/metabolism , Adult , Female , Humans , Intra-Abdominal Fat/metabolism , Male , Methylenetetrahydrofolate Dehydrogenase (NADP)/genetics , Middle Aged , Minor Histocompatibility Antigens , Obesity/metabolism , Sequence Analysis, RNA , Weight Loss/physiology
8.
Am J Clin Nutr ; 100(2): 524-31, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24965310

ABSTRACT

BACKGROUND: The brain is crucial for the control of food intake, reward, and energy homeostasis. OBJECTIVE: We hypothesized that 1) brain circuits involved in energy homeostasis and reward show different functional connectivity patterns between obese and lean individuals and 2) food intake affects functional connectivity differentially in obese and lean individuals. Therefore, we compared the connectivity of the hypothalamus, amygdala, and posterior cingulate cortex, each probing a distinct network related to energy homeostasis and reward, between obese subjects and lean subjects in the fasting state and after meal ingestion. DESIGN: We acquired 3 Tesla resting-state functional magnetic resonance imaging scans after an overnight fast and after ingestion of a liquid mixed meal in 46 obese female participants [19 with normal glucose tolerance and 27 with type 2 diabetes mellitus (T2DM)] and 12 lean subjects. Functional connectivity of our regions of interest was assessed by using a seed-based correlation approach. RESULTS: No significant differences between normal-glucose-tolerant and T2DM subjects were observed. In the fasting state, the total obese group had stronger hypothalamic connectivity with the medial prefrontal cortex and the dorsal striatum than did the lean subjects. The amygdala was differentially connected to the right insula in obese compared with lean subjects. Food intake dampened hypothalamic connectivity with the frontal regions in lean subjects, whereas these connections were barely affected in obese subjects. CONCLUSIONS: Our results indicate that functional connectivity in several brain networks, particularly the homeostatic and cognitive control network and the reward network, was different between obese and lean subjects. In the fasting state, obesity appears to be associated with stronger functional connectivity between brain areas involved in cognitive control, motivation, and reward, whereas these connections are largely unaffected by food intake in obese compared with lean subjects.


Subject(s)
Amygdala/metabolism , Cognition , Gyrus Cinguli/metabolism , Hypothalamus/metabolism , Nerve Net/metabolism , Obesity/metabolism , Up-Regulation , Adult , Body Mass Index , Brain Mapping , Diabetes Mellitus, Type 2/complications , Fasting , Female , Humans , Insulin Resistance , Magnetic Resonance Imaging , Middle Aged , Motivation , Obesity/complications , Postprandial Period , Reward
9.
Clin Endocrinol (Oxf) ; 81(6): 862-70, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24841294

ABSTRACT

OBJECTIVE: To study the effect of different weight loss strategies on levels of the metabolic regulator FGF21 in morbidly obese females with normal glucose tolerance (NGT) or type 2 diabetes mellitus (T2DM). DESIGN: Observational intervention trial. PATIENTS AND MEASUREMENTS: Weight reduction was achieved by Gastric Banding (GB, n = 11) or Roux-en-Y Gastric Bypass (RYGB, n = 16) in subjects with NGT, and by RYGB (n = 15) or a very-low-calorie diet (VLCD, n = 12) in type 2 diabetics. Fasted and/or postprandial levels of FGF21, FGF19 (an FGF21-related postprandial hormone) and bile salts (implicated in regulation of FGF21 and FGF19 expression) were measured before, and 3 and 12 weeks after intervention. RESULTS: Fasted FGF21 levels were elevated in T2DM subjects. Calorie restriction by either GB or VLCD lowered bile salt and FGF21 levels. In contrast, RYGB surgery was associated with elevated bile salt and FGF21 levels. CONCLUSIONS: Calorie restriction and RYGB have opposite effects on serum bile salt and FGF21 levels. Calorie restriction results in FGF21 approaching nonobese control levels, suggesting that this intervention is effective in reducing the "nutritional crisis" that appears to underly FGF21 elevation in obesity. FGF21 elevation after RYGB may contribute to the beneficial effect of this procedure.


Subject(s)
Caloric Restriction/methods , Diabetes Mellitus, Type 2/blood , Fibroblast Growth Factors/blood , Gastric Bypass/methods , Obesity, Morbid/therapy , Bariatric Surgery/methods , Diabetes Mellitus, Type 2/complications , Female , Humans , Middle Aged , Obesity, Morbid/blood , Obesity, Morbid/complications
10.
Clin Endocrinol (Oxf) ; 81(5): 689-95, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24392723

ABSTRACT

OBJECTIVE: Cardiac ectopic fat depositions are thought to play a role in the pathogenesis of cardiovascular disease (CVD), the main cause of death in patients with type 2 diabetes. Diet-induced weight loss results in a decrease in cardiac ectopic fat stores, however if this is the same for surgically induced weight loss is less clear. Therefore, we assessed myocardial triglyceride (TG) content, pericardial fat and cardiac function in obese patients with insulin-dependent type 2 diabetes before and 16 weeks after Roux-en-Y gastric bypass (RYGB) surgery. PATIENTS: Ten obese patients with insulin-dependent type 2 diabetes [40% male, age 53·7 ± 8·9 years (mean ± SD)] scheduled to undergo RYGB surgery were included. MEASUREMENTS: Ectopic fat accumulation and cardiovascular function were assessed with magnetic resonance (MR) imaging and myocardial TG content with MR spectroscopy before and 16 weeks after RYGB surgery. RESULTS: Body mass index decreased from 41·3 ± 4·3 at baseline to 34·1 ± 2·8 kg/m(2) (P < 0·001) after 16 weeks. Glycemic control improved as well [HbA1c: 7·8 ± 1·1 to 6·8 ± 1·3% (62 ± 12 to 51 ± 14 mm) (P < 0·05)]. We did not observe an effect of the RYGB surgery on myocardial TG content, cardiac function or pulse wave velocity. There was a greater relative decrease in visceral (-35·5 ± 9·6%) as compared to subcutaneous fat volume (-25·0 ± 6·3%) and in paracardial (-17·3 ±17·2%) as compared to epicardial fat volume (-6·4 ± 6·0%). CONCLUSIONS: This study shows that surgical-induced weight loss leads to a larger decrease in paracardial than epicardial fat. Myocardial TG and cardiovascular function did not change.


Subject(s)
Adipose Tissue , Bariatric Surgery , Cardiovascular Physiological Phenomena , Diabetes Mellitus, Type 2/surgery , Obesity, Morbid/surgery , Pericardium/metabolism , Adolescent , Adult , Choristoma , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/physiopathology , Female , Humans , Male , Middle Aged , Obesity, Morbid/complications , Obesity, Morbid/physiopathology , Pericardium/pathology , Pulse Wave Analysis , Young Adult
11.
Metabolism ; 63(4): 492-501, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24467914

ABSTRACT

INTRODUCTION: Obesity is strongly related to type-2 diabetes (T2DM), but there is a subset of obese individuals that remains relatively insulin sensitive and metabolically healthy. This study determined to what extent differences in metabolic health in obese women are associated with differences in adipose tissue and/or systemic inflammation. METHODS: The subject group consisted of age comparable lean (n=12) and obese women either with T2DM (n=28) or normal glucose tolerance (NGT; n=26). Number of crown like structures (CLS) and adipocyte size were measured in subcutaneous and visceral adipose tissue of the obese women. Circulating cytokine and free fatty acid (FFA) levels, as well as number and activation status of peripheral leukocytes were determined. RESULTS: Obese T2DM subjects showed higher circulating levels of IL-6, FFA and glycerol as compared to obese NGT subjects. Obese T2DM subjects had higher absolute numbers of peripheral leukocytes which were mainly due to an increase of T helper cells. Activation status of circulating cytotoxic T (CD8+CD25+) and B (CD19+CD38+) cells was significantly increased in obese NGT subjects as compared to lean but was not different between the two obese groups. Subcutaneous adipose tissue of obese T2DM subjects contained more CLS than adipose tissue of obese NGT subjects. CONCLUSION: Obese T2DM subjects show higher FFA levels and adipose tissue macrophage infiltration in addition to higher levels of circulating IL-6 and numbers of CD4+ T cells than obese NGT subjects. Hence, obese T2DM subjects show a higher extent of inflammation at both the systemic and adipose tissue level.


Subject(s)
Adipose Tissue/physiopathology , Diabetes Mellitus, Type 2/physiopathology , Glucose Tolerance Test , Obesity/physiopathology , Systemic Inflammatory Response Syndrome/physiopathology , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Fatty Acids, Nonesterified/blood , Female , Flow Cytometry , Glycerol/blood , Humans , Hypoglycemic Agents/therapeutic use , Interleukin-6/blood , Lymphocyte Count , Middle Aged , Obesity/blood , Obesity/complications , Systemic Inflammatory Response Syndrome/blood , Systemic Inflammatory Response Syndrome/complications , T-Lymphocyte Subsets
12.
Clin Endocrinol (Oxf) ; 80(6): 834-42, 2014 Jun.
Article in English | MEDLINE | ID: mdl-23711328

ABSTRACT

OBJECTIVE: Roux-en-Y gastric bypass (RYGB) and restrictive weight loss interventions, such as gastric banding (GB) and very-low-calorie diets (VLCD) directly impact glucose metabolism, possibly by calorie restriction and/or altered secretion of gut hormones. We aimed to establish the direct endocrine and metabolic effects of RYGB compared to restrictive interventions in obese glucose-tolerant (NGT) subjects and subjects with type 2 diabetes (T2DM). DESIGN: Controlled, nonrandomized observational trial. PATIENTS AND MEASUREMENTS: Four groups of obese females received a mixed meal at baseline and 3 weeks after intervention; NGT-GB (n = 11), NGT-RYGB (n = 16), T2DM-RYGB (n = 15) and T2DM-VLCD (n = 12). Normal weight controls (n = 12) were studied once. RESULTS: At baseline, all obese subjects were hyperinsulinemic. T2DM was associated with hyperglycaemia and decreased GLP-1 levels. RYGB and VLCD reduced glucose levels to a similar extent in T2DM, insulin levels decreased only after VLCD. Comparison of restrictive intervention vs RYGB showed a more pronounced decrease in glucose and insulin AUC after restriction. In NGT and T2DM subjects, RYGB increased GLP-1 and PYY levels and decreased ghrelin levels, whereas VLCD and GB only increased GIP levels. CONCLUSIONS: These data indicate that deterioration of glucose metabolism in T2DM is associated with a decline of GLP-1 levels. Calorie restriction facilitates glucose metabolism and blunts hyperinsulinemia in obese (diabetic) humans. Additional duodenal exclusion through RYGB induces gut hormone release and hyperinsulinemia but does not improve postprandial glucose levels any further. Our data thus strongly suggest that calorie restriction underlies the short-term metabolic benefits of RYGB in obese T2DM patients.


Subject(s)
Caloric Restriction , Diabetes Mellitus, Type 2/blood , Gastric Bypass/methods , Obesity/blood , Obesity/surgery , Adiposity , Area Under Curve , Blood Glucose/analysis , Diabetes Complications/blood , Female , Ghrelin/metabolism , Glucose/metabolism , Hormones/metabolism , Humans , Hyperglycemia/blood , Insulin/blood , Insulin Resistance , Intestinal Mucosa/metabolism , Middle Aged , Obesity/complications , Weight Loss
13.
Eur J Endocrinol ; 169(3): 339-47, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23811187

ABSTRACT

OBJECTIVE: Obesity and weight loss influence thyroid hormone physiology. The effects of weight loss by calorie restriction vs Roux-en-Y gastric bypass (RYGB) in obese subjects have not been studied in parallel. We hypothesized that differences in transient systemic inflammation and catabolic state between the intervention types could lead to differential effects on thyroid hormone physiology. DESIGN AND METHODS: We recruited 12 lean and 27 obese females with normal fasting glucose (normal glucose tolerant (NGT)) and 27 obese females with type 2 diabetes mellitus (T2DM) for this study. Weight loss was achieved by restrictive treatment (gastric banding or high-protein-low-calorie diet) or by RYGB. Fasting serum leptin, TSH, triiodothyronine (T3), reverse T3 (rT3), and free thyroxine (fT4) concentrations were measured at baseline and 3 weeks and 3 months after the start of the interventions. RESULTS: Obesity was associated with higher TSH, T3, and rT3 levels and normal fT4 levels in all the subjects when compared with the controls. After 3 weeks, calorie restriction and RYGB induced a decline in TSH levels and a rise in rT3 and fT4 levels. The increase in rT3 levels correlated with serum interleukin 8 (IL8) and IL6 levels. After 3 months, fT4 and rT3 levels returned to baseline levels, whereas TSH and T3 levels were persistently decreased when compared with baseline levels. No differences in the effects on thyroid hormone parameters between the interventions or between NGT and T2DM subjects were observed at any time point. CONCLUSIONS: In summary, weight loss directly influences thyroid hormone regulation, independently of the weight loss strategy used. The effects may be explained by a combination of decreased leptin levels and transient changes in peripheral thyroid hormone metabolism.


Subject(s)
Caloric Restriction , Gastric Bypass , Obesity, Morbid/diet therapy , Obesity, Morbid/surgery , Thyroid Gland/physiopathology , Thyroid Hormones/blood , Adult , Body Mass Index , Caloric Restriction/adverse effects , Combined Modality Therapy/adverse effects , Diabetes Mellitus, Type 2/complications , Diet, Reducing/adverse effects , Female , Gastric Bypass/adverse effects , Gastric Bypass/methods , Humans , Leptin/blood , Middle Aged , Obesity/complications , Obesity/diet therapy , Obesity/physiopathology , Obesity/surgery , Obesity, Morbid/complications , Obesity, Morbid/physiopathology , Thyroid Function Tests , Thyroid Hormones/metabolism , Weight Loss
14.
Eur J Endocrinol ; 169(4): 383-90, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23847327

ABSTRACT

OBJECTIVE: Obesity and type 2 diabetes mellitus (T2DM) are reported to be associated with relative overactivity of the sympathetic nervous system (SNS), which is reversible by weight loss. However, direct effects of weight loss by calorie restriction vs Roux-en-Y gastric bypass (RYGB) on SNS overactivity were not studied in parallel. This study compared the effects of RYGB vs restrictive weight loss in obese patients with normal glucose tolerance (NGT) and with T2DM on SNS function as measured by heart rate variability (HRV). DESIGN AND METHODS: Lean (n=12), obese NGT (n=27) and T2DM (n=27) subjects were included in this study. Weight reduction in NGT subjects was achieved by gastric banding (GB) or RYGB and in T2DM subjects by RYGB or high-protein very-low-calorie diet (VLCD). HRV analysis was performed and blood samples were taken at baseline, 3 weeks and 3 months after intervention. RESULTS: At baseline, T2DM subjects showed SNS overactivity and NGT subjects showed similar, but non-significant, findings when compared with lean controls. Weight loss after 3 weeks was comparable in all treatment groups, whereas after 3 months, weight loss was most in VLCD and RYGB subjects. RYGB and VLCD treatment reduced SNS activity within 3 weeks in T2DM patients. After 3 months, restoration to normal autonomic nervous system activity was evident for all groups, except for the NGT-GB group. CONCLUSION: We can conclude that SNS overactivity is more pronounced in obese T2DM subjects when compared with NGT subjects. Reduction of SNS overactivity coincides with weight loss with the time-course of reduction dependent on the type of intervention. Surgery or caloric restriction may transiently induce SNS overactivity but do not prevent a direct restoration of sympathovagal balance.


Subject(s)
Autonomic Nervous System Diseases , Diabetes Mellitus, Type 2/complications , Diet, Reducing , Gastric Bypass , Obesity/diet therapy , Adult , Autonomic Nervous System Diseases/diet therapy , Autonomic Nervous System Diseases/etiology , Autonomic Nervous System Diseases/surgery , Caloric Restriction , Diabetes Mellitus, Type 2/drug therapy , Female , Glucose Tolerance Test , Humans , Hypoglycemic Agents/therapeutic use , Middle Aged , Obesity/complications , Obesity/surgery , Sympathetic Nervous System/physiopathology , Treatment Outcome , Vagus Nerve/physiopathology , Weight Loss
15.
J Rheumatol ; 36(7): 1520-6, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19487270

ABSTRACT

OBJECTIVE: We sought evidence of association of candidate single nucleotide polymorphisms (SNP) within the growth hormone-insulin-like growth factor 1 (IGF1) axis, largely selected on the basis of functional data available at the time of our study, with adult bone mass. METHODS: Four hundred ninety-eight men and 468 women aged 59-71 years were recruited. A lifestyle questionnaire was administered, and bone mineral content (BMC) and bone mineral density (BMD) were measured at the lumbar spine and femoral neck. Two hundred fifty-four men and 271 women had repeat bone densitometry 4 years later. DNA was obtained from whole blood samples using standard extraction techniques. Single nucleotide variants in the growth hormone releasing hormone gene (GHRH, G/A 223 Phe75Leu, rs4988492), growth hormone releasing hormone receptor gene (GHRHR, G/A 217, Ala57Thr, rs4988496), the growth hormone secretagogue receptor gene (GHSR, T/C, Gly57Gly, rs495225), and the growth hormone receptor gene (GHR, T/G, noncoding, rs2940944) were analyzed. RESULTS: In both sexes, allelic variation in the gene encoding GHRH was associated with BMC and BMD at the proximal femur and lumbar spine, with results generally stronger in women. In women, the mean BMC lumbar spine within the GHRH 11 genotype was 56.9 g, while that of the GHRH 12 genotype was 68.4 g [p < 0.001, fully adjusted for age, body mass index, cigarette and alcohol consumption, dietary calcium intake, physical activity, years since menopause, and hormone replacement therapy (HRT) use]; corresponding figures for BMD lumbar spine (GHRH 11 genotype) were 0.96 g/cm(2) versus 1.10 g/cm(2) (p < 0.001 fully adjusted). CONCLUSION: We have demonstrated a relationship between allelic variation in the gene encoding GHRH and bone density; we welcome attempts at replication in other populations.


Subject(s)
Bone Density/genetics , Bone Density/physiology , Growth Hormone/genetics , Growth Hormone/physiology , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/physiology , Polymorphism, Single Nucleotide/genetics , Aged , Cohort Studies , Female , Follow-Up Studies , Genotype , Growth Hormone-Releasing Hormone/genetics , Health Surveys , Humans , Male , Middle Aged , Osteoporosis/epidemiology , Osteoporosis/genetics , Osteoporosis/physiopathology , Receptors, Ghrelin/genetics , Receptors, Neuropeptide/genetics , Receptors, Pituitary Hormone-Regulating Hormone/genetics , Risk Factors , United Kingdom
16.
J Rheumatol ; 34(4): 769-75, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17309124

ABSTRACT

OBJECTIVE: We sought evidence of interaction between single-nucleotide polymorphisms (SNP) in the calcium-sensing receptor (CASR) gene and early life in determination of bone mineral density (BMD) among individuals from the Hertfordshire Cohort Study. METHODS: Four hundred ninety-eight men and 468 women aged 59-71 years were recruited. A lifestyle questionnaire was administered and BMD at lumbar spine and femoral neck was measured. DNA was obtained from whole blood samples using standard extraction techniques. Five SNP of the CASR gene termed CASRV1 (rs1801725, G-->T, S986A), CASRV2 (rs7614486, T-->G, untranslated), CASRV3 (rs4300957, untranslated), CASRV4 (rs3804592 G-->A, intron), and CASRV5 (rs1393189, T-->C, intron) were analyzed. RESULTS: Among women the 11 genotype of the CASRV3 SNP was associated with higher lumbar spine BMD within the lowest birthweight tertile, while the opposite pattern was observed among individuals in the highest birthweight tertile (test for interaction on 1 df, p = 0.005, adjusted for age, body mass index, physical activity, dietary calcium intake, cigarette and alcohol consumption, social class, menopausal status, and hormone replacement therapy use). Similar relationships were seen at the total femur (p = 0.042, fully adjusted) with birthweight and at the total femur according to weight at 1 year tertile among women (p < 0.001, fully adjusted). One haplotype was associated with lumbar spine BMD in women (p = 0.008, fully adjusted); these findings were replicated in a second cohort. CONCLUSION: We have found evidence of an interaction between a SNP of the CASR gene and birthweight in determination of bone mass in a UK female population.


Subject(s)
Birth Weight , Bone Density/genetics , Polymorphism, Single Nucleotide , Receptors, Calcium-Sensing/genetics , Aged , Bone Density/physiology , Cohort Studies , England , Female , Femur/physiology , Haplotypes , Humans , Lumbar Vertebrae/physiology , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...